Recap Evolving HER2+ Metastatic Breast Cancer Landscape

Via Peters

Experts discussed the changing landscape in treatments for HER2-positive metastatic breast cancer. HER2-positive metastatic breast cancer has historically been considered a difficult-to-treat disease given that it is often more aggressive than other breast cancers. However, several recently established targeted treatment options that prolong survival and enhance quality of life now […]